Co-immunoprecipitation (co-IP) assay demonstrated that the shared binding between ASCL1 and OLIG2 may be due to a direct protein-protein interaction since OLIG2 was successfully pulled down with an antibody specific for ASCL1 from PDOX-GBM cells (Fig. 1h, i). The gene discussed is OLIG2; the disease is glioblastoma.